Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Poland Crypto Bill Clears Sejm Again, Defying President — Will “Restrictive” Rules Stick? - 2This Miraculous, Cliff-Perched Town In The South Of France Is A Sacred European Gem
- 3Shipping: The Corridors of Trade and the Coming of Another Period
- 4The Best Web-based Courses for Ability Advancement
- 5The year's first meteor shower and supermoon clash in January skies
- Hilary Duff releases 'Mature,' her 1st song in 10 years
- Famous SUVs With Low Energy Utilization In 2024
- Dominating Your Cash: The Fundamental Manual for Overseeing Individual accounting records
- BioMarin to acquire Amicus Therapeutics for $4.8 billion in rare disease bet
- How to identify animal tracks, burrows and other signs of wildlife in your neighborhood
- Discovery of ancient pleasure boat reveals Egypt's maritime history
- Video Conferencing Instruments for Virtual Gatherings
- Everything you should know before booking a trip to Spain
- Vote In favor of Your Favored Cereal
